Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Butyrylcholinesterase (BCHE)
BuChE; CHE1; E1; Pseudocholinesterase; Cholinesterase; Acylcholine acylhydrolase; Butyrylcholine esterase; Choline esterase II
- Product No.CEC348Ra
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range2.47-200ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.95ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 505
For more details, please contact local distributors! US$ 722 US$ 3249 US$ 6137 US$ 50540
Specificity
This assay has high sensitivity and excellent specificity for detection of Butyrylcholinesterase (BCHE).
No significant cross-reactivity or interference between Butyrylcholinesterase (BCHE) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Butyrylcholinesterase (BCHE) and the recovery rates were calculated by comparing the measured value to the expected amount of Butyrylcholinesterase (BCHE) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 80-92 | 84 |
EDTA plasma(n=5) | 87-97 | 90 |
heparin plasma(n=5) | 91-98 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Butyrylcholinesterase (BCHE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Butyrylcholinesterase (BCHE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Butyrylcholinesterase (BCHE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 90-99% | 80-95% | 86-102% | 85-102% |
EDTA plasma(n=5) | 91-101% | 96-105% | 87-98% | 90-98% |
heparin plasma(n=5) | 92-99% | 98-105% | 84-96% | 83-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study pubmed:28112944 |
International Journal of Molecular Sciences | In Vitro Evaluation and Docking Studies of 5-oxo-5H-furo [3, 2-g] chromene-6-carbaldehyde Derivatives as Potential Anti-Alzheimer's Agents Pubmed: 31683761 |
BMC Anesthesiology | Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a … Pubmed: 32988385 |
scientific reports | Neuropsychopharmacological profiling of scoparone in mice Pubmed:35039558 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
RPC348Ra01 | Recombinant Butyrylcholinesterase (BCHE) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC348Ra01 | Polyclonal Antibody to Butyrylcholinesterase (BCHE) | WB; IHC; ICC; IP. |
MAC348Ra21 | Monoclonal Antibody to Butyrylcholinesterase (BCHE) | WB; IHC; ICC; IP. |
SEC348Ra | ELISA Kit for Butyrylcholinesterase (BCHE) | Enzyme-linked immunosorbent assay for Antigen Detection. |
CEC348Ra | ELISA Kit for Butyrylcholinesterase (BCHE) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC348Ra | Multiplex Assay Kit for Butyrylcholinesterase (BCHE) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSC348Ra11 | ELISA Kit DIY Materials for Butyrylcholinesterase (BCHE) | Main materials for "Do It(ELISA Kit) Yourself" |